ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCA10 | ATP-binding cassette, sub-family A (ABC1), member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA12 | ATP-binding cassette, sub-family A (ABC1), member 12 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCA13 | ATP-binding cassette, sub-family A (ABC1), member 13 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCA2 | ATP-binding cassette, sub-family A (ABC1), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA5 | ATP-binding cassette, sub-family A (ABC1), member 5 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted membrane proteins Transporters
| | | | | Mixed |
ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | Predicted membrane proteins Transporters
| | | | | Mixed |
ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB10 | ATP-binding cassette, sub-family B (MDR/TAP), member 10 | Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB6 | ATP-binding cassette, sub-family B (MDR/TAP), member 6 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB9 | ATP-binding cassette, sub-family B (MDR/TAP), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC10 | ATP-binding cassette, sub-family C (CFTR/MRP), member 10 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC12 | ATP-binding cassette, sub-family C (CFTR/MRP), member 12 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Mixed |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC9 | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ABCD1 | ATP-binding cassette, sub-family D (ALD), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCD4 | ATP-binding cassette, sub-family D (ALD), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ABCG4 | ATP-binding cassette, sub-family G (WHITE), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ACIN1 | Apoptotic chromatin condensation inducer 1 | Plasma proteins Transporters
| | | | | Expressed in all |
ACOT12 | Acyl-CoA thioesterase 12 | Enzymes Transporters
| | | | | Tissue enriched |
ADCYAP1R1 | Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
ADORA1 | Adenosine A1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADRB2 | Adrenoceptor beta 2, surface | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANK2 | Ankyrin 2, neuronal | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Mixed |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO2 | Anoctamin 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO6 | Anoctamin 6 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ANO9 | Anoctamin 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Transporters
| | | | | Expressed in all |
ANXA2 | Annexin A2 | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |